Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mainly induces apoptosis in transformed cells, leaving healthy cells intact, which makes it a potential cancer therapy [9,10]. The gene discussed is TNFSF10; the disease is cancer.